Myelin synthesis

Myelin synthesis" refers to the **complex biological process** by which specialized glial cells—oligodendrocytes in the central nervous system (CNS) and Schwann cells in the peripheral nervous system (PNS)—produce the multilayered lipid-rich membrane known as **myelin**. This sheath wraps around axons, increasing nerve impulse conduction speed via saltatory conduction and providing metabolic support to neurons. The synthesis involves coordinated expression of genes encoding major structural proteins such as **myelin basic protein (MBP)**, **proteolipid protein 1 (PLP1)**, and enzymes for lipid biosynthesis. Regulatory mechanisms include transcriptional control by factors like Sox10/Myrf and post-transcriptional regulation by non-coding RNAs[2][7]. Disruption in any component can lead to impaired nerve function or neurodegeneration. "Myelin synthesis" itself is not a single molecular entity or druggable target but rather an essential developmental and maintenance pathway critical for healthy nervous system function[4][5][6]. Note: "Myelin synthesis" is not a canonical molecule/receptor/therapeutic target but rather describes a physiological process involving many molecules; thus it does not fit standard structured data fields for drug targets.

Other names

Myelin formationMyelinationMyelin biosynthesisSynthesis of myelin